Literature DB >> 1368401

Stability of von Willebrand factor secretion in different human endothelial hybrid cell lines.

O Hohenwarter1, C Schmatz, H Katinger.   

Abstract

Endothelial cells form a highly differentiated tissue on the inner surface of blood vessels. One of the typical characteristics is the expression of von Willebrand Factor, a protein that participates in blood coagulation. The in vitro cultivation of endothelial cells is limited by the fact that primary cells become senescent after 40 generation doublings. We have immortalized human endothelial cells by somatic cell hybridization. Primary cells were fused to different tumor cell lines of murine and human origin. The degree of differentiation of the resulting hybrids was analyzed by characterizing the expression of von Willebrand Factor. This protein was identified intracellularly and in the culture supernatant. During long-term cultivation the hybrid cells showed a tendency to lose this differentiated property even after several subcloning steps. However by fusing them with primary endothelial cells a second time, cell lines expressing von Willebrand Factor for more than 180 population doublings were generated.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1368401     DOI: 10.1007/bf02540027

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  15 in total

1.  The serial cultivation of human diploid cell strains.

Authors:  L HAYFLICK; P S MOORHEAD
Journal:  Exp Cell Res       Date:  1961-12       Impact factor: 3.905

2.  Endothelial cell hybrids and the suspension of factor VIII related antigen expression.

Authors:  C J Edgell; H M Reisner; J B Graham
Journal:  Br J Haematol       Date:  1980-12       Impact factor: 6.998

3.  A simple cytochemical technique for demonstration of DNA in cells infected with mycoplasmas and viruses.

Authors:  W C Russell; C Newman; D H Williamson
Journal:  Nature       Date:  1975-02-06       Impact factor: 49.962

4.  Human X (mouse X human) hybridomas stably producing human antibodies.

Authors:  L Ostberg; E Pursch
Journal:  Hybridoma       Date:  1983

5.  An endothelial cell growth factor from bovine hypothalamus: identification and partial characterization.

Authors:  T Maciag; J Cerundolo; S Ilsley; P R Kelley; R Forand
Journal:  Proc Natl Acad Sci U S A       Date:  1979-11       Impact factor: 11.205

Review 6.  von Willebrand factor and von Willebrand disease.

Authors:  Z M Ruggeri; T S Zimmerman
Journal:  Blood       Date:  1987-10       Impact factor: 22.113

Review 7.  Genetic suppression of tumor formation: a new frontier in cancer research.

Authors:  R Sager
Journal:  Cancer Res       Date:  1986-04       Impact factor: 12.701

8.  Structure of pre-pro-von Willebrand factor and its expression in heterologous cells.

Authors:  D T Bonthron; R I Handin; R J Kaufman; L C Wasley; E C Orr; L M Mitsock; B Ewenstein; J Loscalzo; D Ginsburg; S H Orkin
Journal:  Nature       Date:  1986 Nov 20-26       Impact factor: 49.962

9.  NEW CYTOPLASMIC COMPONENTS IN ARTERIAL ENDOTHELIA.

Authors:  E R WEIBEL; G E PALADE
Journal:  J Cell Biol       Date:  1964-10       Impact factor: 10.539

10.  Immunolocalization of von Willebrand protein in Weibel-Palade bodies of human endothelial cells.

Authors:  D D Wagner; J B Olmsted; V J Marder
Journal:  J Cell Biol       Date:  1982-10       Impact factor: 10.539

View more
  3 in total

1.  Two distinct NF-kappa B complexes differing in their larger subunit bind the E-selectin promoter kappa B element.

Authors:  R Hooft van Huijsduijnen; R Pescini; J F DeLamarter
Journal:  Nucleic Acids Res       Date:  1993-08-11       Impact factor: 16.971

2.  Analysis of mitogenic activity of proteins after separation by gel electrophoresis.

Authors:  O Hohenwarter; G Marzban; E Jisa; K Vorauer-Uhl; H Katinger
Journal:  Cytotechnology       Date:  1999-07       Impact factor: 2.058

Review 3.  Modeling human endothelial cell transformation in vascular neoplasias.

Authors:  Victoria W Wen; Karen L MacKenzie
Journal:  Dis Model Mech       Date:  2013-09       Impact factor: 5.758

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.